150 related articles for article (PubMed ID: 32710945)
21. Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma.
Liu H; Wu L; Ji K; Wang W
Tumour Biol; 2015 Sep; 36(10):7375-84. PubMed ID: 26361957
[TBL] [Abstract][Full Text] [Related]
22. Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma.
Johnson TG; Schelch K; Cheng YY; Williams M; Sarun KH; Kirschner MB; Kao S; Linton A; Klebe S; McCaughan BC; Lin RCY; Pirker C; Berger W; Lasham A; van Zandwijk N; Reid G
J Thorac Oncol; 2018 Feb; 13(2):258-272. PubMed ID: 29113949
[TBL] [Abstract][Full Text] [Related]
23. Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma.
Martínez-Rivera V; Negrete-García MC; Ávila-Moreno F; Ortiz-Quintero B
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462963
[TBL] [Abstract][Full Text] [Related]
24. The secretome signature of malignant mesothelioma cell lines.
Manfredi M; Martinotti S; Gosetti F; Ranzato E; Marengo E
J Proteomics; 2016 Aug; 145():3-10. PubMed ID: 26921831
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA Signatures in Malignant Pleural Mesothelioma Effusions.
Birnie KA; Prêle CM; Musk AWB; de Klerk N; Lee YCG; Fitzgerald D; Allcock RJN; Thompson PJ; Creaney J; Badrian B; Mutsaers SE
Dis Markers; 2019; 2019():8628612. PubMed ID: 31481984
[TBL] [Abstract][Full Text] [Related]
26. miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an "ALT-like" phenotype in diffuse malignant peritoneal mesothelioma cells.
Cimino-Reale G; Gandellini P; Santambrogio F; Recagni M; Zaffaroni N; Folini M
J Hematol Oncol; 2017 Jul; 10(1):140. PubMed ID: 28716051
[TBL] [Abstract][Full Text] [Related]
27. CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives.
Cortes-Dericks L; Schmid RA
Respir Res; 2017 Apr; 18(1):58. PubMed ID: 28403901
[TBL] [Abstract][Full Text] [Related]
28. Are circulating microRNAs suitable for the early detection of malignant mesothelioma? Results from a nested case-control study.
Weber DG; Brik A; Casjens S; Burek K; Lehnert M; Pesch B; Taeger D; Brüning T; Johnen G;
BMC Res Notes; 2019 Feb; 12(1):77. PubMed ID: 30744695
[TBL] [Abstract][Full Text] [Related]
29. Localized Intrasplenic Mesothelioma: A Case Report.
Giansanti M; Bellezza G; Guerriero A; Pireddu A; Sidoni A
Int J Surg Pathol; 2014 Aug; 22(5):451-5. PubMed ID: 24050959
[TBL] [Abstract][Full Text] [Related]
30. Regulation of microRNA using promising dietary phytochemicals: Possible preventive and treatment option of malignant mesothelioma.
Sayeed MA; Bracci M; Lucarini G; Lazzarini R; Di Primio R; Santarelli L
Biomed Pharmacother; 2017 Oct; 94():1197-1224. PubMed ID: 28841784
[TBL] [Abstract][Full Text] [Related]
31. Circulating miR-132-3p as a Candidate Diagnostic Biomarker for Malignant Mesothelioma.
Weber DG; Gawrych K; Casjens S; Brik A; Lehnert M; Taeger D; Pesch B; Kollmeier J; Bauer TT; Johnen G; Brüning T
Dis Markers; 2017; 2017():9280170. PubMed ID: 28321148
[TBL] [Abstract][Full Text] [Related]
32. Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.
van Zandwijk N; Pavlakis N; Kao SC; Linton A; Boyer MJ; Clarke S; Huynh Y; Chrzanowska A; Fulham MJ; Bailey DL; Cooper WA; Kritharides L; Ridley L; Pattison ST; MacDiarmid J; Brahmbhatt H; Reid G
Lancet Oncol; 2017 Oct; 18(10):1386-1396. PubMed ID: 28870611
[TBL] [Abstract][Full Text] [Related]
33. Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease.
Cavalleri T; Angelici L; Favero C; Dioni L; Mensi C; Bareggi C; Palleschi A; Rimessi A; Consonni D; Bordini L; Todaro A; Bollati V; Pesatori AC
PLoS One; 2017; 12(5):e0176680. PubMed ID: 28472171
[TBL] [Abstract][Full Text] [Related]
34. Iron addiction with ferroptosis-resistance in asbestos-induced mesothelial carcinogenesis: Toward the era of mesothelioma prevention.
Toyokuni S
Free Radic Biol Med; 2019 Mar; 133():206-215. PubMed ID: 30312759
[TBL] [Abstract][Full Text] [Related]
35. Clinical evaluation of circulating miR-548a-3p and -20a expression in malignant pleural mesothelioma patients.
Matboli M; Shafei AE; Azazy AE; Reda M; El-Khazragy N; Nagy AA; Ali MA; Sobhi M; Abdel-Rahman O
Biomark Med; 2018 Feb; 12(2):129-139. PubMed ID: 29338319
[TBL] [Abstract][Full Text] [Related]
36. miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma.
Williams M; Kirschner MB; Cheng YY; Hanh J; Weiss J; Mugridge N; Wright CM; Linton A; Kao SC; Edelman JJ; Vallely MP; McCaughan BC; Cooper W; Klebe S; Lin RC; Brahmbhatt H; MacDiarmid J; van Zandwijk N; Reid G
Oncotarget; 2015 Sep; 6(27):23480-95. PubMed ID: 26125439
[TBL] [Abstract][Full Text] [Related]
37. Blockage of epithelial to mesenchymal transition and upregulation of let 7b are critically involved in ursolic acid induced apoptosis in malignant mesothelioma cell.
Sohn EJ; Won G; Lee J; Yoon SW; Lee I; Kim HJ; Kim SH
Int J Biol Sci; 2016; 12(11):1279-1288. PubMed ID: 28090191
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma.
Pantazopoulos I; Boura P; Xanthos T; Syrigos K
Eur Respir J; 2013 Mar; 41(3):706-15. PubMed ID: 22835614
[TBL] [Abstract][Full Text] [Related]
39. Two cases of malignant peritoneal mesothelioma without asbestos exposure: cytologic and immunohistochemical features.
Kinoshita Y; Takasu K; Yuri T; Yoshizawa K; Uehara N; Kimura A; Miki H; Tsubura A; Shikata N
Ann Diagn Pathol; 2013 Feb; 17(1):99-103. PubMed ID: 22784439
[TBL] [Abstract][Full Text] [Related]
40. [microRNAs as biological indicators of environmental and occupational exposure to asbestos].
Minoia C; Sturchio E; Porro B; Ficociello B; Zambelli A; Imbriani M
G Ital Med Lav Ergon; 2011; 33(4):420-34. PubMed ID: 22452101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
